296 results on '"Vendrely, Véronique"'
Search Results
52. Bioactive food components for colorectal cancer prevention and treatment: A good match.
53. A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort
54. An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid
55. Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma
56. Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head
57. Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma
58. Neoadjuvant Chemoradiotherapy Improves Histological Results Compared with Perioperative Chemotherapy in Locally Advanced Esophageal Adenocarcinoma
59. Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
60. Additional file 3 of Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?
61. Additional file 2 of Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?
62. Additional file 1 of Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?
63. Bioactive food components for colorectal cancer prevention and treatment: A good match
64. Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery
65. Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID
66. 1929: Organ preservation in rectal cancer: the GRECCAR12 randomized phase 3 trial (NCT02514278).
67. Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review
68. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
69. Epithelial growth factor receptor (EGFR) pathway and renal cell carcinoma
70. Circulating Tumor Cell Clusters: United We Stand Divided We Fall
71. Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
72. Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer
73. MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma
74. Efforts to Improve Local Control in Rectal Cancer Compromise Survival by the Potential Morbidity of Optimal Mesorectal Excision
75. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes
76. Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
77. Surgical Resection after Radiochemotherapy in Patients with Unresectable Adenocarcinoma of the Pancreas
78. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery
79. Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
80. Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
81. Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
82. How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort
83. Prognostic factors in esophageal cancer treated with curative intent
84. GRECCAR2 trial: details worthy of more attention – Authors' reply
85. Chemoradiation for Unresectable Pancreatic Cancer Can Improve Quality of Life and Does Not Exclude Potential Resection
86. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
87. Role of 18F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma
88. Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial
89. Pancreatic adenocarcinoma : What is the real outcome of patients with major response to neoadjuvant treatment ?
90. Pancreatic cancer with vascular involvment: Neoadjuvant treatment or not?
91. Comparative analysis of Circulating Tumour Cells detection and circulating tumor DNA in liquid biopsy for the diagnosis of early stage pancreatic adenocarcinoma
92. Role of 18F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma.
93. Traitement des cancers du canal anal : où en sommes-nousmaintenant ?
94. Locally Advanced Pancreatic Adenocarcinoma: Reassessment of Response with CT after Neoadjuvant Chemotherapy and Radiation Therapy
95. Comparaison de la radiochimiothérapie néoadjuvante à la chimiothérapie périopératoire dans la prise en charge des adénocarcinomes localement avancés de l’œsophage
96. Neoadjuvant Chemoradiotherapy Improves Histological Results Compared with Perioperative Chemotherapy in Locally Advanced Esophageal Adenocarcinoma
97. Low Rectal Cancer
98. An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment
99. Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
100. Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.